SCHEMBL23259602

SCHEMBL23259602

CNc1ccc2ccccc2c1/N=N/c1ccc(/N=N/c2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 3/20 0.58
▸ KMT2A Q03164 10/20 0.51
▸ MEN1 O00255 9/20 0.51
▸ MAPT P10636 8/20 0.51
▸ L3MBTL1 Q9Y468 5/20 0.51
▸ TDP1 Q9NUW8 4/20 0.51
▸ GAA P10253 2/20 0.51
▸ LMNA P02545 2/20 0.51
▸ RECQL P46063 2/20 0.51
▸ ALPL P05186 1/20 0.51
▸ HSP90AA1 P07900 1/20 0.51
▸ ALPI P09923 1/20 0.51
▸ ALPG P10696 1/20 0.51
▸ CASP3 P42574 1/20 0.51
▸ MMP14 P50281 1/20 0.51
▸ SENP8 Q96LD8 1/20 0.51
▸ SENP7 Q9BQF6 1/20 0.51
▸ SENP6 Q9GZR1 1/20 0.51
▸ MAPK1 P28482 4/20 0.49
▸ RAB9A P51151 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28417737 1.00 THRB (0.58) THRBKMT2AMEN1MAPTL3MBTL1
SCHEMBL39613 0.84 THRB (0.53) THRBKMT2AMEN1MAPTL3MBTL1
SCHEMBL29353433 0.84 THRB (0.53) THRBKMT2AMEN1MAPTL3MBTL1
SCHEMBL867583 0.84 THRB (0.53) THRBKMT2AMEN1MAPTL3MBTL1
SCHEMBL12133347 0.79 THRB (0.62) THRBKMT2AMEN1MAPTL3MBTL1
SCHEMBL11696238 0.77 THRB (0.48) THRBKMT2AMEN1MAPTL3MBTL1
SCHEMBL11875107 0.77 THRB (0.48) THRBKMT2AMEN1MAPTL3MBTL1
SCHEMBL11784126 0.76 THRB (0.50) THRBKMT2AMEN1MAPTL3MBTL1
SCHEMBL11685404 0.76 CNR1 (0.47) THRBKMT2AMEN1MAPTL3MBTL1
SCHEMBL11685397 0.76 CNR1 (0.47) THRBKMT2AMEN1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210115489-A1 NOVEL MEDIATOR KIKKOMAN CORPORATION (JP) 2021-04-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115489-A1 NOVEL MEDIATOR MPO, EPX, LPO THRB 4364/4885KMT2A 3104/4885MEN1 2351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback